After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
BNTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of BioNTech SE ADR is $28.82B. A total of 0.86 million shares were traded on the day, compared to an average of 791.21K shares.
In the most recent transaction, ATHOS KG bought 4,983 shares of BNTX for 120.69 per share on Dec 13 ’24. In a previous transaction on Dec 11 ’24, ATHOS KG bought 22,450 shares at 116.85 per share.
Among the insiders who bought shares, ATHOS KG acquired of 53,716 shares on Dec 09 ’24 at a per-share price of $121.72. In another insider transaction, ATHOS KG bought 13,104 shares at $118.84 per share on Dec 06 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BNTX has a high of $131.49 and a low of $76.53.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BNTX’s latest balance sheet shows that the firm has $2.07B in Cash & Short Term Investments as of fiscal 2021. There were $301.50M in debt and $3.48B in liabilities at the time. Its Book Value Per Share was $88.98, while its Total Shareholder’s Equity was $11.89B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BNTX is Buy with a score of 4.50.